Stockreport

Lumos Pharma: LUM-201 In PGHD Offers Significant Upside Potential [Seeking Alpha]

Ascendis Pharma A/S - Ordinary Share  (ASND) 
Last ascendis pharma a/s - ordinary share earnings: 11/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ascendispharma.com
PDF SummaryLumos Pharma, Inc. is a clinical-stage biopharmaceutical company that currently trades around a 50% discount to pro forma cash.The company is developing LUM-201 ( [Read more]